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Table 1. Characteristics in 1997 of subjects included in 
survival analyses (N=195) and analyses on health-related 
quality of life in 2003 (N=99) 
 
LONGITUDINAL PERFORMANCE ASSESSMENT  
FOR PREDICTING ADVERSE OUTCOMES IN OLDER 
COMMUNITY-DWELLING MEN  
THE ADDED VALUE TO SINGLE TIME POINT TIMED UP AND GO ASSESSMENT  
To assess whether the change of patients’ Timed Up and Go 
(TUG) performance over time (longitudinal assessment) 
adds value to the prediction of all-cause mortality and 
health-related quality of life compared to single time point 
TUG assessment at baseline, in older community-dwelling 
men. 
 Longitudinal study: started in 1996 with follow-up visits annually until 
2000, one visit in 2003, and thereafter follow-up by telephone.  
 Population-based sample of 352 ambulatory older men (Merelbeke)  
 The TUG test was performed at each visit until 2000 to assess subjects’ 
physical performance. Mean annual change in performance time was 
calculated using linear regression analyses with data from 1997 until 
2000.  
 Data on all-cause mortality were obtained by contacting proxies and 
the treating general practitioners by telephone. The most recent update 
was completed on 31 December 2011. Cox proportional hazards model 
adjusted for age and baseline TUG were used. 
 Health-related Quality of Life was assessed using eight subscales of 
the Short Form-36 (Range 0 – 100, higher scores indicate better quality 
of life). Associations with low quality of life in 2003 were examined 
using logistic regression models adjusted for age and baseline TUG. 
 Subjects with low performance (TUG > 20s) or function (RDRS-2 > 16 / 
32) at baseline and subjects who were deceased before 2000 were 
excluded from the analyses. 
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Longitudinal assessment of physical performance adds value to the 
prediction of all-cause mortality and low health-related quality of life 
compared to single time point TUG assessment at baseline.  
Take home message: 
Our results encourage annual assessment of physical performance in 
order to track decline after baseline. 
  N = 195 N = 99 
1997 Median (IQR)  Median (IQR)  
Age (years) 75 (73 – 77) 74 (73 – 77) 
BMI (kg / m²) 26.6 (24.6 – 28.7) 26.6 (24.7 – 28.4) 
Medication 2 (1 – 4) 2 (1 – 3) 
TUG test (sec) 10.50 (9.11 – 12.30) 10.35 (8.95 – 11.63) 
Annual decline in TUG (sec / year) 0.05 (-0.4 – 0.6)  -0.08 (-0.45 – 0.26) 
Survival Time (years) 8.3 (3.9 – 11.3) 11.3 (7.3 – 11.4) 
General Health score (SF36 item) 65 (55 – 80) 70 (59 – 80) 
  HR 95% CI Wald P 
Age (years) 1.07 1.02 – 1.13 7.1 0.008 
TUG test (sec) 1.08 1.00 – 1.17 3.5 0.060 
Annual decline  
in TUG (sec / year) 
1.40 1.17 – 1.68 13.3 < 0.001 
By the end of 2011 N (%) 
Alive 65 (33.3%) 
Deceased  129 (66.2%) 
Lost to follow-up 1 (0.5%) SF-36 scale  
(cut-off value corresponding to 
lowest quartile in 2000) 
Odds 
Ratio 
95% CI 
Wald 
statistic 
P 
General Health (< 50) 1.05 0.55 – 1.99 0.02 0.880 
Mental Health (< 68) 0.90 0.48 – 1.69 0.11 0.740 
Vitality (< 60) 1.14 0.60 - 2.15 0.15 0.695 
Bodily Pain (< 64) 1.96 0.99 – 3.91 3.68 0.055 
Physical Function (< 55) 2.29 1.12 - 4.71 5.10 0.024 
Social Function (< 75) 2.10 1.07 - 4.14 4.60 0.032 
Physical Role (< 25) 2.02 1.01 - 4.05 3.90 0.048 
Emotional Role (< 67) 1.20 0.63 – 2.28 0.32 0.574 
Table 4. Logistic regression models with annual decline in 
TUG (sec/year) predicting low health-related quality of 
life in 2003 (adjusted for age and baseline TUG) (N=99) 
Table 2. Survival characteristics (N=195) 
Table 3. Cox regression analysis 
predicting all-cause mortality (N=195) 
Figure 1. Age-adjusted 
survival curve (N=195) 
